Human cannabinoid pharmacokinetics MA Huestis Chemistry & biodiversity 4 (8), 1770, 2007 | 1347 | 2007 |
Neuropsychological performance in long-term cannabis users HG Pope, AJ Gruber, JI Hudson, MA Huestis, D Yurgelun-Todd Archives of general psychiatry 58 (10), 909-915, 2001 | 954 | 2001 |
Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications MS Castaneto, DA Gorelick, NA Desrosiers, RL Hartman, S Pirard, ... Drug and alcohol dependence 144, 12-41, 2014 | 843 | 2014 |
Cannabis effects on driving skills RL Hartman, MA Huestis Clinical chemistry 59 (3), 478-492, 2013 | 804 | 2013 |
Early-onset cannabis use and cognitive deficits: what is the nature of the association? HG Pope Jr, AJ Gruber, JI Hudson, G Cohane, MA Huestis, ... Drug and alcohol dependence 69 (3), 303-310, 2003 | 767 | 2003 |
Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid R Dams, MA Huestis, WE Lambert, CM Murphy Journal of the American Society for Mass Spectrometry 14 (11), 1290-1294, 2003 | 740 | 2003 |
Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana MA Huestis, JE Henningfield, EJ Cone Journal of analytical Toxicology 16 (5), 276-282, 1992 | 726 | 1992 |
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers J Hirvonen, RS Goodwin, CT Li, GE Terry, SS Zoghbi, C Morse, VW Pike, ... Molecular psychiatry 17 (6), 642-649, 2012 | 673 | 2012 |
Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716 MA Huestis, DA Gorelick, SJ Heishman, KL Preston, RA Nelson, ... Archives of general psychiatry 58 (4), 322-328, 2001 | 648 | 2001 |
Oral fluid testing for drugs of abuse WM Bosker, MA Huestis Clinical chemistry 55 (11), 1910-1931, 2009 | 464 | 2009 |
Cannabidiol adverse effects and toxicity MA Huestis, R Solimini, S Pichini, R Pacifici, J Carlier, FP Busardò Current neuropharmacology 17 (10), 974-989, 2019 | 435 | 2019 |
Pharmacokinetics and Metabolism of the Plant Cannabinoids, Δ 9-Tetrahydrocannibinol, Cannabidiol and Cannabinol MA Huestis Cannabinoids, 657-690, 2005 | 403 | 2005 |
The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report BM Lester, M ElSohly, LL Wright, VL Smeriglio, J Verter, CR Bauer, ... Pediatrics 107 (2), 309-317, 2001 | 368 | 2001 |
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome HE Jones, RE Johnson, DR Jasinski, KE O’Grady, CA Chisholm, ... Drug and alcohol dependence 79 (1), 1-10, 2005 | 346 | 2005 |
The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth LM Smith, LL LaGasse, C Derauf, P Grant, R Shah, A Arria, M Huestis, ... Pediatrics 118 (3), 1149-1156, 2006 | 310 | 2006 |
Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers RJF Schepers, JM Oyler, RE Joseph Jr, EJ Cone, ET Moolchan, ... Clinical chemistry 49 (1), 121-132, 2003 | 305 | 2003 |
Cannabis effects on driving lateral control with and without alcohol RL Hartman, TL Brown, G Milavetz, A Spurgin, RS Pierce, DA Gorelick, ... Drug and alcohol dependence 154, 25-37, 2015 | 299 | 2015 |
Plasma Cannabinoid Pharmacokinetics following Controlled Oral Δ9-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration EL Karschner, WD Darwin, RS Goodwin, S Wright, MA Huestis Clinical chemistry 57 (1), 66-75, 2011 | 281 | 2011 |
Relationship of Δ9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis MA Huestis, EJ Cone Journal of analytical toxicology 28 (6), 394-399, 2004 | 274 | 2004 |
Interpretation of oral fluid tests for drugs of abuse EJ Cone, MA Huestis Annals of the New York Academy of Sciences 1098 (1), 51-103, 2007 | 247 | 2007 |